Skip to main content

Advertisement

SpringerLink
Log in

Serum erythropoietin level in anemic cancer patients

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Anemia is a frequent complication of cancer and its treatment. A defect in erythropoietin production has been advocated as being the main cause of anemia in cancer patients. We studied serum erythropoietin levels in 74 patients with solid tumors and in a control group consisting of 20 otherwise healthy individuals without any malignancy, who have only iron deficiency anemia. Serum erythropoietin levels were measured by enzyme immunoassay in cancer patients without anemia (n=34), and in anemic cancer patients (n=40); either receiving chemotherapy (n=21) or not (n=19). Anemic cancer patients were found to have decreased response of erythropoietin for a given hemoglobin level (mean, 40.1±34.7 u/ml), compared with the patients having only iron deficiency anemia (mean, 69.7±68.6 u/ml) (P<0.05). In patients with iron deficiency anemia having no malignancy, erythropoietin response was remarkably high and inversely correlated with the level of hemoglobin (r=−0.69;P=0.05). Although there was no correlation between hemoglobin and erythropoietin response in cancer anemia (r=−0.07), serum levels of erythropoietin were found to be higher in anemic cancer patients (mean, 40.1±34.7 u/ml), compared with cancer patients with normal hemoglobin values (mean, 19.96±18.4 u/ml). There was not any statistically significant difference between erythropoietin levels in anemic cancer patients with or without chemotherapy (mean, 43.7±37.7 u/ml and 41.9±30.08 u/ml respectively;P>0.05). No difference in serum erythropoietin levels were noted in patients treated with cisplatin or non-cisplatin containing regimens (mean, 48.36±33.12 u/ml and 38.55±43.52 u/ml, respectively;P>0.05). In this study, we demonstrated that anemia in cancer patients was caused by blunted erythropoietin response, rather than its quantitative deficiency. Serial measurements, however, should be considered in patients receiving chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aglietta M. Diagnostic approach to the anemic cancer patient.Tumori 1997;83 (4): S20-S25.

    CAS  PubMed  Google Scholar 

  2. Cartwright GE. The anemia of chronic disorders.Semin Haematol 1966;3: 351–375.

    CAS  Google Scholar 

  3. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer.N Engl J Med 1993;328: 1372–1376.

    Article  CAS  PubMed  Google Scholar 

  4. Heiss MMet al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.J Clin Oncol 1994;12: 1859–1867.

    Article  CAS  PubMed  Google Scholar 

  5. Thomas ML. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.Med Oncol 1998;15 (Suppl 1): S13-S18.

    PubMed  Google Scholar 

  6. Graber SE, Krantz SB. Erythropoietin and the control of red cell production.Ann Rev Med 1978;29: 51–66.

    Article  CAS  PubMed  Google Scholar 

  7. Spivak JL. Serum immunoreactive erythropoietin in health and disease.J Perinat Med 1995;23: 13–17.

    Article  CAS  PubMed  Google Scholar 

  8. Zucker S, Friedman S, Lysik RM. Bone marrow erytropoiesis in the anemia of infection, inflammation and malignancy.J Clin Invest 1974;53: 1132–1138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Schreuder WO, Ting WC, Smith S, Jacobs A. Testosterone, erythropoietin, and anemia in patients with disseminated bronchial cancer.Br J Haematol 1984;57: 521–526.

    Article  CAS  PubMed  Google Scholar 

  10. Cox R, Musial T, Gyde OHB. Reduced erythropoietin levels as a cause of anemia in patients with lung cancer.Eur J Cancer Clin Oncol. 1986;22: 511–514.

    Article  CAS  PubMed  Google Scholar 

  11. Miller JB, Jones RJ, Piontadosi S, Abeloff M, Spivak JL. Decreased erythropietin response in patients with the anemia of cancer.N Engl J Med 1990;322(24): 1689–1692.

    Article  CAS  PubMed  Google Scholar 

  12. Nowrousian MRet al. Pathophysiology of cancer-related anemia. In: JF Smyth, MA Boogaerts, BRM Ehmer (eds.).rhErythropoietin in Cancer Supportive Treatment 1996; pp 13–34.

  13. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease.Blood 1992;80: 1639–1647.

    Article  PubMed  Google Scholar 

  14. Joosten Eet al. Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia.J Am Geriatr Soc 1993;41 (12): 1301–1304.

    Article  CAS  PubMed  Google Scholar 

  15. Honda Ket al. Anemia-inducing substance from plasma of patients with advanced malignant neoplasms.Cancer Res 1995;55: 3623–3628.

    CAS  PubMed  Google Scholar 

  16. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance.Ann Hematol 1994;68: 215–223.

    Article  CAS  PubMed  Google Scholar 

  17. Ludwig H, Fritz E. Anemia in cancer patients.Semin Oncol 1998;3 (Suppl 7): 2–6.

    Google Scholar 

  18. Birgegard G, Wide L, Simonsson B. Marked erythropoietin increase before fall in hemoglobin after treatment with cytostatic drugs suggest mechanism other than anemia for stimulation.Br J Haematol 1989;72: 462–466.

    Article  CAS  PubMed  Google Scholar 

  19. Hasegawa I, Tanaka K. Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy.Gynecol Oncol 1992;46(1): 65–68.

    Article  CAS  PubMed  Google Scholar 

  20. Shamseddine Aet al. The relation between erythropoietin, hematocrit, and hemoglobin in breast cancer patients on non-nephrotoxic chemotherapy.Eur J Gynaecol Oncol 1998;19(6): 577–579.

    CAS  PubMed  Google Scholar 

  21. Wood P, Nygaand S, Hrushesky WJM. Cisplatin induced anemia is correctable with erythropoietin.Blood 1988;72 (Suppl): 52 (Abstract).

    Google Scholar 

  22. Saijo Yet al. Changes in serum erythropoietin levels during chemotherapy for lung cancer.Chemotherapy 1992;38(5): 281–285.

    Article  CAS  PubMed  Google Scholar 

  23. Beguin Y. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.Med Oncol 1998;15 (Suppl 1): S38-S46.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cerrahpasa School of Medicine, Department of Internal Medicine, Section of Medical Oncology, Istanbul University, Yogurtcu Basi sok. Akcira apt. 20/3, Dalyan, Fenerbahce, 81030, istanbul, Turkey

    M Ozguroglu, G Demir, F Demirelli, NM Mandel, E Buyukunal, S Serdengecti & B Berkarda

  2. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA

    B Arun

Authors
  1. M Ozguroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Arun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Demirelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. NM Mandel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Buyukunal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Serdengecti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B Berkarda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Ozguroglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozguroglu, M., Arun, B., Demir, G. et al. Serum erythropoietin level in anemic cancer patients. Med Oncol 17, 29–34 (2000). https://doi.org/10.1007/BF02826213

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02826213

Keywords

Search

Navigation